Epigenomic changes in Alzheimer’s: ANK1 DNA methylation
Katie Lunnon, PhD, PGCAP, of the University of Exeter, Exeter, UK, discusses the last 5 years in epigenomics for Alzheimer’s. She highlights studies of ANK1 DNA methylation across different...
View ArticleThe UK Dementia Research Institute (DRI)
Hugh Perry, BSc, MA, DPhil, of the University of Southampton, Southampton, UK, outlines the structure of the UK Dementia Research Institute and their work across dementias. This interview took place at...
View ArticleVEGF in Alzheimer’s disease
Seth Love, MBBCh, PhD, MRCP/FRCP, MRCPath/FRCPath, of the University of Bristol, Bristol, UK, speaks at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK and discusses his...
View ArticleReduced cerebral oxygenation and cognitive impairment
There is almost always a reduction in cerebral oxygenation in the human brain afflicted with Alzheimer’s disease. Seth Love, MBBCh, PhD, MRCP/FRCP, MRCPath/FRCPath, of University of Bristol, Bristol,...
View ArticleDPUK MR-PET harmonization for dementia research
Karl Herholz, MD, FRCP, of the University of Manchester, Manchester, UK, speaks at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK, where he discusses the aims and rationale...
View ArticleDementias Platform UK Datathons: get involved!
Sarah Bauermeister, BA Hons, BSc Hons, MSc, PhD, CPsychol, Senior Researcher and Data Manager for Dementias Platform UK (DPUK), from the University of Oxford, Oxford, UK, discusses the DPUK datathon...
View ArticleDPUK x Uni of Exeter Dementias Datathon
David Llewellyn, PhD, of the University of Exeter Medical School, Exeter & The Alan Turing Institute, London, UK, discusses the Dementias Platform UK (DPUK) Datathon taking place at the University...
View ArticleThe protective effect of NTF
Wipawan Thangnipon, PhD, of Mahidol University, Salaya, Thailand, speaks at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK and discusses her research into the protective role...
View ArticleMicroglial activation in Alzheimer’s
Paul Edison, MD, PhD, MPhil, FRCP, FRCPI, of Imperial College London, London, UK, discusses microglial activation, its role in early Alzheimer trajectory. This interview took place at the Alzheimer’s...
View ArticleDEMON network for dementia data science collaboration
David Llewellyn, PhD, of the University of Exeter Medical School, Exeter & The Alan Turing Institute, London, UK, discusses the deep dementia phenotypying network (DEMON), providing an...
View Article